Spark Therapeutics (ONCE) Misses Q2 EPS by 66c

Spark Therapeutics (NASDAQ: ONCE) reported Q2 EPS of ($2.40), $0.66 worse than the analyst estimate of ($1.74). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.06 million.

For earnings history and earnings-related data on Spark Therapeutics (ONCE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c